ft 15 jul 93 intern compani news genentech result show sharp increas genentech us bio technolog compani 60 per cent own roch switzerland lift second quarter net incom dollar 10 4m dollar 3 4m year earlier driven jump incom product sale licens increas earn per share 9 cent 3 cent year earlier though 12 cent first quarter help lift compani share dollar 1 2 close dollar 44 1 4 new york sale activas heart drug compani biggest sell product continu recov declin larg account slump compani 1992 earn follow result end april 40 000 patient trial sale activas rose dollar 55 8m quarter dollar 49 2m first three month dollar 44 6m second quarter 1992 overal product sale increas dollar 110 8m dollar 95 8m second quarter 1992 contract incom jump dollar 5 3m dollar 24 3 due larg dollar 18 2m contribut three year licenc agreement schere total revenu dollar 169 8m dollar 153m first quarter dollar 136m second three month 1992 compani normal high research develop spend jump dollar 83 9m dollar 73 3m took charg dollar 13 7m end agreement involv research institut molecular patholog vienna r amp effort yield two signific develop quarter start develop work new heart drug decis us food drug administr review genentech cystic fibrosi treatment former mr kirk raab chairman said molecul perform well clinic laboratori could advanc treatment heart attack even activas